About TellBio
TellBio is a private company based in Andover, Massachusetts. It has reported $10,973,031 raised in five offerings on Form D since October 2019.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 2024 | Oct 18, 2024amended Mar 24, 2026 | $1,000,000fully sold | 6 | $166K | Equity, OptionsRule 506(b) | Form D/A ↗2 earlier filings |
| Jun 21, 2024 | Jul 8, 2024 | $1,200,000fully sold | 11 | $109K | Equity, DebtRule 506(b) | Form D ↗ |
| Feb 24, 2023 | Mar 29, 2023 | $2,294,702of $2.5M target | 23 | $99,770 | EquityRule 506(b) | Form D ↗ |
| Mar 11, 2021 | Mar 17, 2021 | $4,999,998fully sold | 29 | $172K | EquityRule 506(b) | Form D ↗ |
| Sep 30, 2019 | Oct 22, 2019 | $1,478,331fully sold | 19 | $77,807 | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $10,973,031 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on TellBio's Form D filed Mar 24, 2026.
Earlier filings also listed Pritesh Gandhi (ceo and director, last listed Jul 2024).